Skip navigation
  • Sciety Labs 🧪 (Experimental)
  • Search
Sciety application utilities

Neurology

  • Subscribe to feed (RSS)

Showing page 7 of 17 pages of list content

  • Breakthrough SARS-CoV-2 infections in MS patients on disease modifying therapies

    This article's authors
    1. Irene Schiavetti
    2. Cinzia Cordioli
    3. Maria Laura Stromillo
    4. Maria Teresa Ferrò
    5. Alice Laroni
    6. Eleonora Cocco
    7. Gaia Cola
    8. Livia Pasquali
    9. Maria Teresa Rilla
    10. Elisabetta Signoriello
    11. Rosa Iodice
    12. Alessia Di Sapio
    13. Roberta Lanzillo
    14. Francesca Caleri
    15. Pietro Annovazzi
    16. Antonella Conte
    17. Giuseppe Liberatore
    18. Francesca Ruscica
    19. Renato Docimo
    20. Simona Bonavita
    21. Monica Ulivelli
    22. Paola Cavalla
    23. Francesco Patti
    24. Diana Ferraro
    25. Marinella Clerico
    26. Paolo Immovilli
    27. Massimiliano Di Filippo
    28. Marco Salvetti
    29. Maria Pia Sormani
    30. the “Breakthrough infections in MS” study group
    This article has 1 evaluations Latest evaluation on Feb 2, 2022 Published on Jan 31, 2022
  • Correlation between leukocyte phenotypes and prognosis of amyotrophic lateral sclerosis: a longitudinal cohort study

    This article's authors
    1. Can Cui
    2. Caroline Ingre
    3. Li Yin
    4. Xia Li
    5. John Andersson
    6. Christina Seitz
    7. Nicolas Ruffin
    8. Yudi Pawitan
    9. Fredrik Piehl
    10. Fang Fang
    This article has 4 evaluations Latest evaluation on Feb 2, 2022 Published on Oct 7, 2021
  • Persistently reduced humoral and cellular immune response following third SARS-CoV-2 mRNA vaccination in anti-CD20-treated multiple sclerosis patients

    This article's authors
    1. Hamza Mahmood Bajwa
    2. Frederik Novak
    3. Anna Christine Nilsson
    4. Christian Nielsen
    5. Dorte K. Holm
    6. Kamilla Østergaard
    7. Agnes Hauschultz Witt
    8. Keld-Erik Byg
    9. Isik S. Johansen
    10. Kristen Mittl
    11. William Rowles
    12. Scott S. Zamvil
    13. Riley Bove
    14. Joseph J. Sabatino
    15. Tobias Sejbaek
    This article has 1 evaluations Latest evaluation on Feb 1, 2022 Published on Jan 28, 2022
  • SARS-CoV-2 third vaccine immune response in MS patients treated with ocrelizumab

    This article's authors
    1. Livnat Brill
    2. Catarina Raposo
    3. Ariel Rechtman
    4. Omri Zveik
    5. Netta Levin
    6. Esther Oiknine-Djian
    7. Dana G. Wolf
    8. Adi Vaknin-Dembinsky
    This article has 1 evaluations Latest evaluation on Feb 1, 2022 Published on Jan 28, 2022
  • Post-COVID-19 Memory Complaints: Prevalence and Associated Factors

    This article's authors
    1. Mashrur Ahmed
    2. Simanta Roy
    3. Sreshtha Chowdhury
    4. Mohammad Azmain Iktidar
    5. Sharmin Akhter
    6. A. M. Khairul Islam
    7. Mohammad Delwer Hossain Hawlader
    This article has 1 evaluations Latest evaluation on Jan 28, 2022 Published on Feb 17, 2022
  • Mapping dopaminergic projections in the human brain with resting-state fMRI

    This article's authors
    1. Marianne Oldehinkel
    2. Alberto Llera
    3. Myrthe Faber
    4. Ismael Huertas
    5. Jan K. Buitelaar
    6. Bastiaan R. Bloem
    7. Andre F. Marquand
    8. Rick C. Helmich
    9. Koen V. Haak
    10. Christian F. Beckmann
    This article has 6 evaluations Latest evaluation on Jan 25, 2022 Published on Mar 26, 2021
  • Longitudinal prediction of motor dysfunction after stroke: a disconnectome study

    This article's authors
    1. Lilit Dulyan
    2. Lia Talozzi
    3. Valentina Pacella
    4. Maurizio Corbetta
    5. Stephanie J Forkel
    6. Michel Thiebaut de Schotten
    This article has 2 evaluations Latest evaluation on Mar 30, 2022 Published on Oct 3, 2022
  • Prognostic Value of Serum/Plasma Neurofilament Light Chain for COVID-19 Associated Mortality

    This article's authors
    1. Ruturaj R. Masvekar
    2. Peter Kosa
    3. Kimberly Jin
    4. Kerry Dobbs
    5. Michael A. Stack
    6. Riccardo Castagnoli
    7. Virginia Quaresima
    8. Helen C. Su
    9. Luisa Imberti
    10. Luigi D. Notarangelo
    11. Bibiana Bielekova
    This article has 1 evaluations Latest evaluation on Jan 18, 2022 Published on Jan 14, 2022
  • Cellular and humoral immunity to SARS-CoV-2 infection in multiple sclerosis patients on ocrelizumab and other disease-modifying therapies: a multi-ethnic observational study

    This article's authors
    1. Ilya Kister
    2. Yury Patskovsky
    3. Ryan Curtin
    4. Jinglan Pei
    5. Katherine Perdomo
    6. Zoe Rimler
    7. Iryna Voloshyna
    8. Marie I. Samanovic
    9. Amber R. Cornelius
    10. Yogambigai Velmurugu
    11. Samantha Nyovanie
    12. Joseph Kim
    13. Ethan Tardio
    14. Tamar E. Bacon
    15. Lana Zhovtis Ryerson
    16. Pranil Raut
    17. Rosetta Pedotti
    18. Kathleen Hawker
    19. Catarina Raposo
    20. Jessica Priest
    21. Mark Cabatingan
    22. Ryan C. Winger
    23. Mark J. Mulligan
    24. Michelle Krogsgaard
    25. Gregg J. Silverman
    This article has 1 evaluations Latest evaluation on Jan 12, 2022 Published on Jan 10, 2022
  • Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies

    This article's authors
    1. Maria Pia Sormani
    2. Irene Schiavetti
    3. Matilde Inglese
    4. Luca Carmisciano
    5. Alice Laroni
    6. Caterina Lapucci
    7. Valeria Visconti
    8. Carlo Serrati
    9. Ilaria Gandoglia
    10. Tiziana Tassinari
    11. Germana Perego
    12. Giampaolo Brichetto
    13. Paola Gazzola
    14. Antonio Mannironi
    15. Maria Laura Stromillo
    16. Cinzia Cordioli
    17. Doriana Landi
    18. Marinella Clerico
    19. Elisabetta Signoriello
    20. Jessica Frau
    21. Maria Teresa Ferrò
    22. Alessia Di Sapio
    23. Livia Pasquali
    24. Monica Ulivelli
    25. Fabiana Marinelli
    26. Marcello Manzino
    27. Graziella Callari
    28. Rosa Iodice
    29. Giuseppe Liberatore
    30. Francesca Caleri
    31. Anna Maria Repice
    32. Susanna Cordera
    33. Mario Alberto Battaglia
    34. Marco Salvetti
    35. Diego Franciotta
    36. Antonio Uccelli
    37. the CovaXiMS study group
    This article has 1 evaluations Latest evaluation on Jan 3, 2022 Published on Dec 27, 2021
Previous Next
Stay updated. Get involved.
Subscribe to Mailing List
  • Blog
  • About Sciety
  • Contact
  • Follow us on Twitter
  • Follow us on Facebook
© 2022 eLife Sciences Publications Ltd. Legal information